NCT01797809View on ClinicalTrials.gov

Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea

CompletedOBSERVATIONAL
Enrollment

757

Participants

Timeline

Start Date

May 11, 2013

Primary Completion Date

January 16, 2018

Study Completion Date

May 8, 2018

Conditions
Contraception
Interventions
DRUG

EV/DNG (Qlaira, BAY86-5027)

Patients in daily life clinical practice tratment receiving Qlaira according to indication on the label.

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01797809 - Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea | Biotech Hunter | Biotech Hunter